8-K: TerrAscend Expands NJ Footprint with Union Chill Acquisition

TerrAscend Corp. has finalized its option agreement to acquire a 35% equity interest in Union Chill Cannabis Company, expanding its New Jersey retail presence and projecting immediate financial accretion.

Summary

• TerrAscend Corp. closed an option agreement on December 26, 2025, to acquire a 35% equity interest in Union Chill Cannabis Company LLC, a high-performing dispensary in Hunterdon County, New Jersey.
• The total consideration for the option is $13,000,000, comprising $9,000,000 in convertible promissory notes and an additional $4,000,000 in cash payable upon the exercise of the option.
• The convertible notes accrue interest at 6.5% per annum, payable quarterly, and mature on December 26, 2029. They are convertible into common shares at a price of $1.89 per share.
• This transaction expands TerrAscend's retail footprint in New Jersey to four dispensaries.
• Union Chill currently generates over $11 million in annualized revenue and is expected to be immediately accretive to TerrAscend's EBITDA and cash flow.
• The transaction aligns with New Jersey's regulatory framework designed to facilitate investment opportunities for diversely owned businesses.
• Upon full exercise of the option and additional conditions, TerrAscend expects to fully consolidate Union Chill's business, increasing its total consolidated retail footprint to 20 dispensaries across five U.S. states and Canada.

Sentiment

Score: 8

Explanation: The filing presents a strong positive outlook, highlighting strategic expansion, immediate financial accretion, and significant revenue generation from the acquired asset. The structured financing also appears favorable. The primary mitigating factor is the inherent federal illegality risk of the cannabis industry in the U.S.

Positives

• Expands TerrAscend's retail footprint in New Jersey to four dispensaries, strengthening its leadership position in the state.
• Union Chill is a high-performing dispensary generating over $11 million in annualized revenue.
• The transaction is expected to be immediately accretive to TerrAscend's EBITDA and cash flow.
• The dispensary is strategically located in Hunterdon County with limited competition within a 10-mile radius.
• Integration of TerrAscend's premium brand portfolio is expected to drive increased sales, margins, and long-term value.
• The structure of the deal, utilizing convertible notes, defers a portion of the cash outlay until the option is exercised.

Negatives

• NA

Risks

• Cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, making it illegal under federal law to cultivate, distribute, or possess cannabis in the United States.
• Financial transactions involving proceeds from cannabis-related business activities in the U.S. may lead to prosecution under federal money laundering legislation.
• Compliance with state laws regarding cannabis does not absolve the Company of liability under U.S. federal law, nor does it provide a defense against federal proceedings.
• The enforcement of federal laws in the United States poses a significant risk that could adversely affect the Company's operations and financial performance.
• General risks include current and future market conditions, the regulatory environment, and the availability of licenses, approvals, and permits.

Future Outlook

TerrAscend expects the Union Chill transaction to be immediately accretive to its EBITDA and cash flow. The company anticipates driving increased sales, margins, and long-term value through the integration of its premium brand portfolio. Upon full exercise of the option and additional conditions, TerrAscend plans to fully consolidate Union Chill's business, further expanding its retail footprint and strengthening its market position in New Jersey.

Management Comments

• "Union Chill will strengthen our leadership position in New Jersey with the addition of a high-performing dispensary strategically located in Hunterdon County."
• "This dispensary is well situated with limited competition within a 10-mile radius and is currently generating over $11 million in annualized revenue."
• "With the integration of our premium brand portfolio, we expect to drive increased sales, margins, and long-term value."

Industry Context

This acquisition reinforces TerrAscend's strategic focus on expanding its retail presence in key U.S. cannabis markets, specifically New Jersey. The move leverages New Jersey's regulatory framework designed to support diversely owned businesses, allowing TerrAscend to grow its footprint in a competitive and growing adult-use market. The addition of a high-performing dispensary with limited local competition positions TerrAscend to capture a larger market share and capitalize on the state's cannabis demand.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: Potential for increased shareholder value due to expected accretion to EBITDA and cash flow, and expanded market presence.
• Employees: Integration of Union Chill's operations may lead to organizational adjustments or new opportunities.
• Customers: Expanded retail footprint in New Jersey provides more access to TerrAscend's product offerings.
• Creditors: The issuance of convertible notes adds to the company's debt structure, with a maturity date in December 2029.

Next Steps

• Exercise the option to purchase the remaining equity interest in Union Chill Cannabis Company LLC.
• Fully consolidate Union Chill's business into TerrAscend's financial results upon option exercise and satisfaction of additional conditions.
• Integrate TerrAscend's premium brand portfolio into the Union Chill dispensary to drive increased sales and margins.

Key Dates

Recommendation

The acquisition of Union Chill is a strategically sound move, expanding TerrAscend's presence in the high-growth New Jersey cannabis market with a high-performing asset. The immediate accretion to EBITDA and cash flow, coupled with the potential for increased sales and margins, indicates strong financial benefits. While federal illegality remains a systemic risk for U.S. cannabis operators, this transaction strengthens TerrAscend's operational footprint and financial profile within the current regulatory environment, making it an attractive investment for long-term growth.

Keywords

Cannabis, Dispensary, New Jersey, Acquisition, Retail Expansion, TerrAscend, Union Chill, Convertible Notes, EBITDA Accretion, Cannabis Regulation